An open label clinical trial of reboxetine in patients with major depressive disorder

被引：0
|
作者：
Demir, B
Soykan, A
Devrimci-Ozguven, H
Gögüs, A
Haller, T
机构：
[1] Univ Hacettepe, Dept Psychiat, TR-06100 Ankara, Turkey
[2] Ankara Univ, Dept Psychiat, TR-06100 Ankara, Turkey
[3] Pharmacia Canada, CNS, Markham, ON, Canada
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S221 / S221
页数：1
相关论文
共 50 条
  • [21] Reboxetine as an optional treatment for hyperkinetic conduct disorder: A prospective open-label trial
    Mozes, T
    Meiri, G
    Ben-Amity, G
    Sabbagh, M
    Weizman, A
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (02) : 259 - 269
  • [22] Reboxetine in seasonal affective disorder: an open trial
    Hilger, E
    Willeit, M
    Praschak-Rieder, N
    Stastny, J
    Neumeister, A
    Kasper, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 (01) : 1 - 5
  • [23] Duloxetine in the treatment of major depressive disorder: an open-label study
    Hudson, James I.
    Perahia, David G.
    Gilaberte, Inmaculada
    Wang, Fujun
    Watkin, John G.
    Detke, Michael J.
    BMC PSYCHIATRY, 2007, 7 (1) : 43
  • [24] Duloxetine in the treatment of major depressive disorder: an open-label study
    James I Hudson
    David G Perahia
    Inmaculada Gilaberte
    Fujun Wang
    John G Watkin
    Michael J Detke
    BMC Psychiatry, 7
  • [25] MAJOR DEPRESSIVE DISORDER, ANHEDONIA, AND AGOMELATINE: AN OPEN-LABEL STUDY
    Martinotti, G.
    Di Iorio, G.
    Guglielmo, R.
    De Berardis, D.
    Janiri, L.
    Di Giannantonio, M.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [26] MAJOR DEPRESSIVE DISORDER, ANHEDONIA AND AGOMELATINE: AN OPEN-LABEL STUDY
    di Giannantonio, M.
    Di Iorio, G.
    Guglielmo, R.
    De Berardis, D.
    Conti, C. M.
    Acciavatti, T.
    Cornelio, M.
    Martinotti, G.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2011, 25 (01): : 109 - 114
  • [27] Open-label tiagabine monotherapy for major depressive disorder with anxiety
    Carpenter, LL
    Schecter, JM
    Tyrka, AR
    Mello, AF
    Mello, MF
    Haggarty, R
    Price, LH
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (01) : 66 - 71
  • [28] An open-label trial of reboxetine in children and adolescents with attention-deficit/hyperactivity disorder
    Tehrani-Doost, Mehdi
    Moallemi, Shirin
    Shahrivar, Zahra
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (02) : 179 - 184
  • [29] Switching to reboxetine: An efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine
    Fava, M
    McGrath, PJ
    Sheu, WP
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (04) : 365 - 369
  • [30] Efficacy of Buspirone Augmentation of Escitalopram in Patients with Major Depressive Disorder with and without Atypical Features: A Randomized, 8 Week, Multicenter, Open-Label Clinical Trial
    Shin, Cheolmin
    Ko, Young-Hoon
    Shim, Se-Hoon
    Kim, Ji Sun
    Na, Kyoung-Sae
    Hahn, Sang-Woo
    Lee, Seung-Hwan
    PSYCHIATRY INVESTIGATION, 2020, 17 (08) : 796 - 803
12345